インターフェロン- εは腫瘍抑制剤であり,卵巣がんを抑制する
Zoe R C Marks1,2, Nicole K Campbell1,2, Niamh E Mangan1,2
1Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Nature
|August 16, 2023
まとめ
インターフェロン-エプシロン (IFNε) は,腫瘍細胞を直接抑制し,抗腫瘍免疫を活性化することで,卵巣がんにおける腫瘍抑制剤として作用する. 腫瘍発達の過程で失われることが 進行した卵巣がんの治療の可能性を強調しています
科学分野:
- 免疫学
- 腫瘍学
- 分子生物学
背景:
- 高度血清性卵巣がん (HGSOC) は,遅い検出と化学抵抗により生存率が低い.
- HGSOCの病原性をより深く理解することで,新しい治療戦略が必要である.
- 卵管上皮質で表されるタンパク質であるインターフェロン-エプシロン (IFNε) は,HGSOCの発達中に失われます.
研究 の 目的:
- 卵巣がんにおけるインターフェロン-エプシロン (IFNε) の内在的腫瘍抑制作用を調査する.
- IFNεの抗腫瘍効果の背後にあるメカニズムを解明する.
- 卵巣がんに対するIFNεの治療の可能性を調査する.
主な方法:
- 様々な臨床前モデル (異種移植,シンゲニックモデル,細胞系) でのIFNεの抗腫瘍活動の特徴.
- IFNε受容体 (IFNAR1) の操作とIFN信号伝達の評価
- 免疫細胞集団の分析,T細胞,自然キラー細胞,骨髄系由来抑制細胞,および調節性T細胞を含む.
主要な成果:
- IFNεは,複数の臨床前卵巣がんモデルで有意な抗腫瘍活性を示しています.
- IFNεは,腫瘍細胞に直接作用し,抗腫瘍免疫を活性化する.
- IFNεは,抗腫瘍T細胞と自然キラー細胞の活動を促進し,骨髄系由来の抑制細胞と調節性T細胞を抑制する.
結論:
- インターフェロン-エプシロン (IFNε) は女性生殖器の内在的な腫瘍抑制剤として機能する.
- IFNεの独特の作用機構は,他のタイプIインターフェロンとは異なり,卵巣がんに対する有望な治療方法を提供します.
- IFNεをターゲットにすることで,既定および進行した卵巣がんに対する新しい治療戦略を提供することができる.
関連する概念動画
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556


